Scientific publications

Chronic migraine: a therapeutic challenge for clinicians

Irimia P [SP], Carmona-Abellán M [SP], Martínez-Vila E.
Department of Neurology, Clinica Universidad de Navarra , Avenida Pío XII, 36, 31008-Pamplona , Spain

Magazine: Expert Opinion on Emergeging Drugs

Date: Sep 21, 2012

Neurology [SP]

ABSTRACT
Chronic migraine is a common disabling condition. Severe migraine attacks should be treated with triptans, but these agents are contraindicated in patients with vascular problems and may not be effective or tolerated in around one third of the patients. New acute migraine therapies without vasoconstrictive activity and triptan-specific side effects are emerging. For the prophylaxis of chronic migraine, only topiramate and Onabotulinumtoxin.

A have been shown to be effective in placebo-controlled randomized trials, so novel therapeutic strategies are needed. The growing understanding of the pathophysiology of chronic migraine will contribute to the identification of new treatment targets.

CITA DEL ARTÍCULO   2012 Sep 21

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra